INBX
USDInhibrx Biosciences Inc. Common Stock
$81.990+2.120 (2.654%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$79.870
High
$83.370
Low
$78.050
Volume
0.34M
Company Fundamentals
Market Cap
1.2B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.31M
Exchange
NMS
Currency
USD
52-Week Range
Low $10.805Current $81.990High $83.95
Related News
PR Newswire
Inhibrx Biosciences Reports Positive Topline Results from its Registrational Trial of Ozekibart (INBRX-109) in Chondrosarcoma and Provides Updates on Colorectal Cancer and Ewing Sarcoma Expansion Cohorts
Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.